Vivo Capital

Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases.

BiotechHealthtechMedical DevicesNorthbrook, US

JAJeffrey Aronin(Director)inJMJeffrey M. Dayno, M.D.(President and Chief Executive Officer)inPatrick Morris(Secretary and Treasurer)inRobert Repella(Director and Chief Executive Officer)Darien Parhad(Chief Financial Officer)

BoardARAaron Royston(Director)in

Board seatJNJack Nielsen· per SEC Form D

Co-investorsAIAisling CapitalPAParagon Biosciences LLCVAValor Equity PartnersVEvenBio PartnersNONovo HoldingsVEvenBio Global Strategic

Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.

BiotechDigital HealthFemTechHealthtechSalt Lake City, US

Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)inGregory C. Critchfield(Executive Officer, Director)inAAAndrew A. Sauter(Executive Officer)inZhenya Lindgardt(President and Chief Executive Officer)in

BoardMansoor Mirza(Director)

Board seatJoseph Siletto· per SEC Form D

Co-investorsAMaMoonEXExcelestar VenturesOUOUP (Osage University Partners)UPUpStart VenturesCACatalyst Health VenturesDODomain Associates

Aadi Bioscience develops therapies targeting mTOR-driven diseases using precision medicine and albumin-bound nanoparticle technology, applying genomic profiling to identify patients most likely to benefit from mTOR inhibition.

BiotechHealthtechMorristown, US

Scott Giacobello(Executive Officer)inBryan Ball(Executive Officer)DLDave Lennon(Executive Officer, Director)inDDDavid Dornan(Executive Officer)James Murphy(Executive Officer)Stephen Pakola(Executive Officer)

Co-investors3B3B Future Health FundALAlly Bridge GroupDEDecheng CapitalAVAvoro VenturesOROrbiMed

Achieve Life Sciences is a late-stage specialty pharmaceutical company developing cytisinicline, a treatment for nicotine dependence and smoking cessation.

BiotechHealthtechVancouver, B.C., US

Anthony Clarke(Executive Officer)RSRichard Stewart(Director)CJCindy Jacobs(Executive Officer, Director)inJXJaime Xinos(Executive Officer)inJBJohn Bencich(Executive Officer, Director)inAndrew D. Goldberg(Director, Chief Executive Officer and President)in

Co-investorsVEvenBio PartnersFRFrazier Life Sciences

Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases.

BiotechHealthtechMedical DevicesWayne, US

Neal Walker(Executive Officer, Director)Kamil Ali-Jackson(Executive Officer)SDStuart D. Shanler(Executive Officer)inJoseph Monahan(Executive Officer)inHDHugh Davis(Executive Officer, Director)inJames Loerop(Executive Officer)

Co-investorsAIAisling CapitalAPAPERTURE Venture PartnersF-F-Prime CapitalFOForesite CapitalRARA CapitalSOSofinnova Ventures+1 more

Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.

BiotechDigital HealthMental HealthMountain View, US

AEAmit Etkin(Founder)inASAdam Savitz(Executive Officer)inNicholas C. Smith(Executive Officer)inMHMichael Hanley(Executive Officer)Nicholas Smith(Chief Financial Officer and Chief Business Officer)inAaron Weaver(Director)

Co-investorsABAble PartnersALAlpha Wave GlobalINInVivium CapitalK2K2 HealthVenturesKOKorify CapitalWHWhat If Ventures+4 more

ALX Oncology develops therapies for cancer treatment, operating in the biotechnology and medical technology sectors.

BiotechHealthtechMedical Devices

CGCorey Goodman(Chairman)inJLJason Lettmann(Chief Executive Officer)in

Co-investorsLILightstone VenturesAGage1FOForesite CapitalVEvenBio PartnersLOLogos

Bolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer.

BiotechHealthtechMedical DevicesSan Francisco, US

DEDr. Edgar G. Engleman(Founder)

Co-investorsPFPfizer Venture InvestmentsRARA CapitalSASamsara BioCapitalSOSofinnova VenturesNANan Fung Life SciencesNONovo Holdings+3 more

Compass Pathways develops novel treatments for mental health conditions, with a focus on psychedelic-assisted therapies supported by rigorous clinical research.

BiotechDigital HealthHealthtechMedical DevicesMental Health

Kabir Nath(CEO)

Co-investorsABAble PartnersAIAisling CapitalCACatalio Capital Management, LPNONoeticOMOMX VenturesJAJam Fund

Compass Therapeutics uses proprietary antibody discovery platforms to generate and screen diverse panels of monoclonal and multispecific antibodies, aiming to identify synergistic therapeutic combinations.

BiotechHealthtechCambridge, US

STSchuetz Thomas(Executive Officer, Director)inEAErrik Anderson(Executive Officer, Director)inTJThomas J. Schuetz(Executive Officer, Director)inVered Bisker-Leib(Executive Officer)inBarry Shin(Chief Financial Officer)inNLNeil Lerner(Senior Vice President, Chief Accounting Officer)in

Co-investorsBIBioBritF-F-Prime CapitalFOForesite CapitalOROrbiMedVEvenBio PartnersBOBorealis Ventures+1 more

Instil Bio is a biotechnology company that identifies and acquires or licenses therapeutic candidates for development, with a strategic focus on securing additional novel drug candidates targeting diseases with significant unmet medical needs.

BiotechDallas, US

Bronson Crouch(Chief Executive Officer & Chairman of the Board)inSandeep "Steve" Laumas(Chief Financial Officer & Chief Business Officer)inNimish Shah(Director)inGwen Binder(Director)Neil Gibson(Director)George Matcham(Director)

Co-investorsCUCurative VenturesCPCPMGVEVenrock

Mereo BioPharma is a biopharmaceutical company publicly traded on Nasdaq under the ticker MREO.

BiotechHealthtechLondon, GB

JRJohn Richard(Head of Corporate Development and Co-Founder)inCharles Sermon(General Counsel and Co-Founder)Richard Jones(Chief Financial Officer)inJill Henrich(Senior Vice President)inDenise Scots-Knight(Chief Executive Officer)in

BoardDr. Deepa Pakianathan(Non-Executive Director)

Co-investorsPOPontifax Venture CapitalWOWoodford Investment Management

Minerva Neurosciences is a clinical-stage biopharmaceutical company developing product candidates for central nervous system disorders.

BiotechHealthtechWaltham, US

Joseph Reilly(Executive Officer)Geoff Race(Executive Officer)inFred Ahlholm(Executive Officer)inRLRemy Luthringer(Executive Officer, Director)Mark Levine(Executive Officer)

BoardMOMichele Ollier(Director)in

Co-investorsCACare CapitalINIndex VenturesMEMedicxi

Olema is a clinical-stage biopharmaceutical company developing novel therapies for metastatic breast cancer and other endocrine-driven cancers, targeting nuclear receptors and mechanisms of acquired resistance.

BiotechHealthtechSan Francisco, US

Cyrus L. Harmon, Ph.D.(Director)Cyrus Harmon(Executive Officer, Director)inCLCyrus L. Harmon(Director)inDavid C. Myles, Ph.D.(Executive Officer)Sean Bohen, M.D., Ph.D.(Executive Officer, Director)Naseem Zojwalla, M.D.(Executive Officer)in

Co-investorsAVAvoro Capital AdvisorsBABain Capital Life SciencesFOForesite CapitalLILightspeed Venture PartnersRARA CapitalBIBiotechnology Value Fund+1 more

Pasithea is a biotechnology company focused on the discovery and development of therapeutics for central nervous system disorders and RASopathies.

BiotechDeep TechHealthtechVenice, US

LSLawrence Steinman(Director)TRTiago Reis Marques(Chief Executive Officer)inIsrael Maxx Abramowitz(Executive Officer, Director)Craig Auringer(Executive Officer, Director)

Co-investorsJAJanus Henderson Investors

Passage Bio is a biotechnology company developing treatments for central nervous system (CNS) diseases, with a focus on neurodegenerative conditions.

BiotechHealthtechPhiladelphia, US

WCWilliam Chou(Chief Executive Officer)Tadataka Yamada(Executive Officer, Director, Promoter)Stephen Squinto(Executive Officer, Director)in

BoardPHPatrick Heron(Director)inCGCarl Gordon(Director)inThomas Street Address 1 Woiwode(Director)

Co-investorsFRFrazier Life SciencesACAccess BiotechnologyFRFrazier Healthcare PartnersNENew Leaf Venture PartnersOROrbiMedVEVersant Ventures

Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

BiotechDeep TechHealthtechDurham, US

DJDEREK JANTZ(Executive Officer, Director)inMKMATTHEW KANE(Executive Officer, Director)JSJeff Smith(Co-founder)inDJDerek Jantz(Co-founder)inTODD MELBY(Executive Officer)inMAMichael Amoroso(President, Chief Executive Officer)in

Co-investorsAGage1AGAgent CapitalALAliment CapitalBRBrace PharmaF-F-Prime CapitalOCOCV Partners+4 more

Silence Therapeutics is a biotechnology company that discovers and develops short interfering RNA (siRNA) molecules designed to reduce the production of disease-associated proteins through the natural mechanism of RNA interference, with its proprietary mRNAi GOLD platform targeting specific genes in the liver for rare and common diseases.

BiotechLondon

Craig Tooman(Executive Officer)inGiles Campion(Executive Officer)Mark Rothera(Executive Officer, Director)inBarbara Ruskin(Executive Officer)

BoardJames Ede-Golightly(Director)Alistair Gray(Director)

Co-investorsFOForesite CapitalMCMC Healthcare VenturesNENextech Invest

Tarsus is a biopharmaceutical company focused on developing and delivering medicines that target the root cause of serious diseases with high unmet need, including eye conditions.

BiotechHealthtechMedical Devices

BABobak Azamian, MD, PhD(Founder)inBABobak Azamian(President and Chief Executive Officer)inJeffrey Farrow(Chief Financial Officer and Chief Strategy Officer)Seshadri Neervannan(Chief Operating Officer)AMAziz Mottiwala(Chief Commercial Officer)inDWDianne Whitfield(Chief Human Resources Officer)in

Co-investorsAPAPERTURE Venture PartnersFLFlying L PartnersFRFrazier Life SciencesVIVisionary VenturesBABain Capital Life SciencesRTRTW Investments L.P.+1 more

Tenax Therapeutics is a clinical-stage pharmaceutical company developing TNX-103, an oral formulation of the drug levosimendan, to treat pulmonary hypertension resulting from heart failure with preserved ejection fraction (PH-HFpEF).

BiotechDigital HealthHealthtechChapel Hill, US

SRStuart Rich(Chief Medical Officer)LRLawrence R. Hoffman(Interim Chief Financial Officer)inMichael B. Jebsen(Executive Officer)CGChris Giordano(President and Chief Executive Officer)inDRDoug Randall(Chief Business Officer)inTSTom Staab(Chief Financial Officer)in

Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States.

BiotechHealthtechMedical Devices

SDSamantha DuinS(Samantha (Ying) Du(Founder, Chief Executive Officer, Chairperson of the Board of Directors)inYCYajing Chen(Chief Financial Officer)inRGRafael G. Amado(President, Head of Global Research and Development)inFTF. Ty Edmondson(Chief Legal Officer)inJSJosh Smiley(President and Chief Operating Officer)

Co-investorsQIQiming Venture PartnersYUYuanBio Venture CapitalADAdvantech CapitalKLKleiner PerkinsSESequoia Capital

Zenas BioPharma is a biopharmaceutical company developing therapies for autoimmune diseases, with two late-stage drug candidates: obexelimab, a bifunctional monoclonal antibody targeting CD19 and FcγRIIb to suppress B cell activity, and orelabrutinib, an oral BTK inhibitor.

BiotechHealthtechWaltham, US

LOLEON O. MOULDER, JR.(Director)LMLonnie Moulder(Founder, CEO & Chairman)JOSEPH FARMER(Executive Officer)HMHUA MU(Executive Officer, Director)in

BoardPGPATRICK GERALD ENRIGHT(Director)inHONGBO LU(Director)

Co-investorsDEDelos CapitalLOLongitude CapitalNENew Enterprise Associates (NEA)NONorwest Venture PartnersQUQuan CapitalSRSR One Capital Management+1 more

Ascendis Pharma is a biopharmaceutical company developing therapies for hormone-related disorders and rare diseases.

BiotechHealthtechMedical DevicesDenmark, DK

JMJan Møller Mikkelsen(Founder, President and Chief Executive Officer)inGrethe Rasmussen(Executive Officer)inHarald Rau(Executive Officer)Martin Olin(Director)Lotte S?nderbjerg(Executive Officer)MAMartin Auster(Executive Officer)in

Co-investorsAIAisling CapitalAVAvoro Capital AdvisorsFOForesite CapitalRARA CapitalSOSofinnova Ventures

Esco Lifesciences manufactures laboratory equipment, biopharma devices, and IVF medical equipment for clinical, research, and industrial laboratories across more than 100 countries.

Advanced ManufacturingBiotechHardwareHealthtechMedical DevicesSingapore, SG

LLLim Lay Yew(Founder)inLow Yae Foong(Founder)

Co-investorsGIGICNONovo Holdings

Fortis Therapeutics develops therapeutic treatments based on technology licensed from UCSF, with a focus on oncology and other disease areas.

BiotechHealthtechMedical DevicesSan Diego, US

Marc Nasoff(Chief Scientific Officer)

BoardJBJay B. Lichter(Ph.D.)in

Co-investorsLILilly Asia VenturesOSOsage University PartnersAVAvalon BioVenturesOUOUP (Osage University Partners)

Gracell Biotechnologies develops cell therapy manufacturing platforms and treatments, with a focus on CAR-T cell therapies for cancer and autoimmune diseases.

BiotechHealthtechMedical DevicesSuzhou, CN

WWWilliam Wei Caoin

Co-investorsLALAVLILilly Asia VenturesOROrbiMedEXExome Asset ManagementJAJanus Henderson InvestorsPIPivotal Life Sciences+2 more

Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform.

BiotechHealthtechMedical DevicesNew York, US

Sohail Tavazoie(Co-Founder & Chair of Scientific Advisory Board)Masoud Tavazoie(Co-Founder & Advisor)in

Co-investorsSOSofinnova PartnersSASands Capital VenturesSTStart CapitalNONovo Holdings

Neocis develops Yomi, a robotic surgical platform that assists clinicians during dental implant surgery with planning, surgical, and restorative software features.

HealthtechMedical DevicesRoboticsMiami, US

AMAlon Mozes(CEO & Co-Founder)inJSJuan Salcedo(Engineering Fellow & Co-Founder)inJSJUAN SALCEDO(Executive Officer)inAMALON MOZES(Executive Officer, Director)inDMDennis Moses(Chief Technical Officer)inACAndres Carrillo(VP of Product)in

Co-investorsINIntuitive VenturesNONorwest Venture PartnersMIMITHRILMIMithril Capital ManagementB B Capital GroupDFDFJ+3 more

Oricell Therapeutics (原启生物) is a clinical-stage biopharmaceutical company developing cell therapies, including CAR-T products targeting GPRC5D for relapsed/refractory multiple myeloma and GPC3 for advanced liver cancer.

BiotechDeep TechHealthtechShanghai, CN

HYHelen Yang(Founder)in

Co-investorsQIQiming Venture PartnersQUQuan CapitalRTRTW Investments L.P.

ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer.

BiotechHealthtechMedical DevicesHalifax, CA

RARobert Abraham(Co-founder (Interventional Radiologist, MD))inDBDaniel Boyd(Co-founder (Material Scientist))inSKSharon Kehoe(Co-founder (Material Scientist))inAHAnthony Headley(Executive Officer)inGDGary Donofrio(Executive Officer)inMMMichael Mangano(Executive Officer, Director)in

Board seatJoseph Siletto· per SEC Form D · $2.6M raise · filed Nov 2025

Co-investorsEIEight Roads VenturesF-F-Prime Capital

Aligos is a clinical-stage biotechnology company developing therapeutics for liver and viral diseases, including chronic hepatitis B virus (HBV) infection and MASLD/MASH.

BiotechHealthtechSouth San Francisco, US

Leonid Beigelman(President)inLMLawrence M. Blatt(Chairman, President & CEO (Co-founder))inHAHardean Achneck(Executive Officer)inBDBrian Dowd(Executive Vice President - Controller)inLucinda Quan(Executive Vice President - General Counsel)inJSJulian Symons(Executive Vice President, Chief Scientific Officer)in

Board seatJNJack Nielsen· per SEC Form D · $92.2M raise · filed Nov 2023

Co-investorsRORoche Venture FundMPMPM BioVentures 2014

BiotechSan Diego, US

FFFrancois Ferre(Director)MMMagda Marquet(Director)Jorge Garces(Executive Officer)inGreg Hamilton(Executive Officer, Director)Carin Sandvik(Executive Officer)Jeffrey G. Black(Executive Officer)

Board seatYuh-geng Tsay· per SEC Form D · $3M raise · filed Mar 2018

Co-investorsBIBioBritALAlly Bridge GroupWUWuXi Healthcare Ventures

Amyris develops a biomanufacturing platform that uses fermentation and microbial engineering to produce natural ingredients and rare compounds at scale for partners across industries such as specialty chemicals, food ingredients, and consumer products.

Advanced ManufacturingBiotechCleantechNew MaterialsEmeryville, US

NICHOLAS KHADDER(Senior Vice President, General Counsel & Secretary)RARAFFI ASADORIAN(Chief Financial Officer)inJCJoel Cherry(President, Research & Development)inTTTamara Tompkins(Executive Vice President, General Counsel)inJMJohn Melo(President & Chief Executive Officer)inPDPaulo Diniz(Chief Financial Officer)in

Board seatFKFrank Kung· per SEC Form D

Co-investorsKLKleiner PerkinsR7R7 Partners

Mediaspace is a digital agency that designs and builds custom Squarespace websites and provides SEO, digital marketing strategy, and digital advertising services.

AdTechAdvanced ManufacturingAI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHardwareHealthtechMarketing TechMedical DevicesSemiconductorsAtlanta, US

John G. Edwards(Executive Officer, Director)JJJohn Jacobi(Executive Officer)SPSri Peruvemba(Executive Officer)Francois Jeanneau(Executive Officer, Director)Linda Ara(Executive Officer)Michael Vestel(Executive Officer)

Board seatNathan DauJNJack Nielsen· per SEC Form D · $22M raise · filed Dec 2021

Co-investors3E3E Bioventures CapitalKEKeiretsu ForumLILife Sciences Greenhouse InvestmentsTOToba Capital

Readcoor developed an in situ spatial transcriptomics platform using padlock probe rolling circle amplification chemistry to detect and map RNA transcripts across tissue sections, now offered as the Xenium In Situ platform.

BiotechDeep TechHardwareHealthtechCambridge, US

Evan Daugharthy(Cofounder)Richard Terry(Executive Officer, Director)

BoardVictor Tong(Director)Thomas Grogan(Director)

Board seatYuh-geng Tsay· per SEC Form D

Co-investorsLALAVLILilly Asia VenturesDEDecheng CapitalLILilly Ventures

Scientia Vascular develops guidewires, including the Aristotle and Zoom Wire product lines, for general vascular use within the neuro and peripheral vasculatures to introduce and position catheters and other interventional devices.

HealthtechMedical DevicesWest Valley City, US

John Lippert(Executive Officer, Director)Stacy Lippert(Executive Officer, Director)

BoardJeffrey Gladden(Dr. Gladden is a manager of the issuer.)David Bearss(Mr. Bearss is a manager of the issuer.)Rick Randall(Mr. Randall is a manager of the issuer.)Jerry Henley(Mr. Henley is a manager of the issuer.)

Board seatNathan DauJoseph Siletto· per SEC Form D

Co-investorsCOCowles Ventures

HealthtechIrvine, US

Kenny Chang(Executive Officer)W. Ronald Redmond(Director)Vijay Dhaka(Executive Officer)Philong Pham(Executive Officer, Director)Hongsheng Tong(Executive Officer, Director)

Board seatJoseph Siletto· per SEC Form D

Co-investorsBLBlackRockENEndeavour VisionMVMVM Life Science PartnersRTRTW Investments L.P.SOSoleus CapitalVEvenBio Global Strategic

35Pharma is a biopharmaceutical company developing biologics to treat diseases with high unmet medical need.

BiotechHealthtech

Ilia(CEO)Maureen(CSO)

Co-investorsFRFrazier Life SciencesVEvenBio PartnersJAJanus Henderson Investors

ADARx is a clinical-stage biotechnology company developing RNA-targeted therapeutics designed to control the expression of disease-driving genes.

BiotechHealthtechMedical Devices

ZLZhen Li(Co-founder, President & CEO)inRZRui Zhu(Founding Member & Chief Technology Officer)RARob Ackles(Chief People Officer)inRFRyan Fisk(Chief Financial Officer & Chief Business Officer)inRARobert A. MacLeod(Chief Scientific Officer)inCCChristopher Claeboe(Senior Vice President of Operations)in

Co-investorsOROrbiMedBABain Capital Life SciencesLILilly Asia VenturesSRSR One Capital ManagementT.T. Rowe PriceTCTCG Crossover

ADAXION develops deimmunized biologic therapies using its ADAx platform, which incorporates proprietary CD22 ligands to eliminate therapeutic-specific B cells and reduce anti-drug antibody responses.

BiotechDeep Tech

Co-investorsJDJDRF T1D Fund

A medical device company developing orthopedic and biological solutions.

BiotechCleantechHardwareHealthtechMedical DevicesOhio, US

DKDavid Kirschman(Surgeon Inventor)in

Co-investorsHOHorizon Technology Finance

Agno Pharmaceuticals is a US-headquartered contract development and manufacturing organization (CDMO) that produces regulatory starting materials, intermediates, active pharmaceutical ingredients, and drug formulations for pharmaceutical and biotech companies.

Advanced ManufacturingBiotechHealthtechUnknown (US-headquartered stated, but specific city not provided), US

Ajax Therapeutics is a biotech company developing Type II JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPNs), including myelofibrosis, using computational chemistry and structural biology in its drug discovery.

AI & Machine LearningBiotechHealthtechNew York, US

Martin Vogelbaum(CEO, co-founder)inRoss Levine(Director)Ramy Farid(Director)

BoardScott Platshon(Director)

Co-investorsINInning One VenturesECEcoR1 CapitalRARA Capital

Akira Bio develops therapies for people living with sickle cell disease and other hemoglobinopathies.

BiotechHealthtech

Co-investorsVEVersant VenturesMPMPM BioImpact

Attralus develops pan-amyloid removal (PAR) therapeutics — biologics and imaging agents designed to bind and remove toxic amyloid — to treat patients with systemic amyloidosis across all disease types and stages.

BiotechHealthtechSouth San Francisco, US

JWJonathan Wall(Executive Officer)inSpencer Guthrie(Executive Officer)MTMark Timney(Executive Officer, Director)inBenson Fong(Executive Officer)RKRahul Kakkar(Director)inGreg Bell(Executive Officer)

Co-investorsALAlpha Wave GlobalBIBioBritVEvenBio PartnersJAJanus Henderson InvestorsREREDMILESASamsara BioCapital+1 more

BH Therapeutics is a drug development company that uses structure-based rational drug design to identify structural limitations in existing therapies and design novel chemical scaffolds to address them.

Biotech

JJJ. Jean Cui, Ph.D.(Scientific Founder, President and CEO)YPY. Peter Li, Ph.D., MBA(Cofounder and Executive Chairman)

Co-investorsOROrbiMed

BioDlink is a contract development and manufacturing organization (CDMO) providing drug development and manufacturing services for biopharmaceutical companies, with specialization in antibody-drug conjugates (ADCs).

Advanced ManufacturingBiotechEnterprise SoftwareHealthtechSuzhou, CN

Bonray Bio develops miniaturized microscopy optics and AI-powered image analysis software for reproductive medicine diagnostics, providing male infertility diagnostic instruments and consumables to fertility clinics globally.

AI & Machine LearningBiotechFemTechHealthtechMedical DevicesTaiwan, TW

Bonum Therapeutics develops antibody-controlled protein therapeutics that remain inactive until bound to their target, using a sensor-domain mechanism to deliver regulated, targeted activity.

BiotechHealthtechSeattle, US

JMJohn Mulligan(Executive Officer, Director, Promoter)inNPNeela Patel(Executive Officer)inDHDiane Hollenbaugh(Executive Officer)in

BoardSBSamuel Bjork(Director)inMSMonique Schiersing(Director)inJMJohn McKearn(Director)in

Co-investorsRIRiverVest Venture PartnersRORoche Venture Fund3X3x5 PartnersCOCodon CapitalDIDigitalis Ventures

Caidya provides clinical trial management solutions designed for pharmaceutical and biotech companies seeking to improve trial efficiency and patient outcomes through integrated, patient-centric approaches.

BiotechDigital HealthHealthtech

BLBarbara Lopez Kunz(Chief Executive Officer)inMCMichael Clay(Chief Operating Officer)inSMSharon Moore(Chief Medical Officer)inBPBrandon Pallott(Chief Commercial Officer)inMLMiron Lila(Chief Corporate Development Officer)inJSJohn Scott(Chief Information Officer)in

Co-investorsHAHatteras Venture Partners

Pharmaceutical company developing medicines and vaccines for patient health and treatment.

BiotechHealthtechSan Diego, US

JSJeffrey Stein(Executive Officer, Director)KJKevin Judice(Director)inKevin Forrest(Executive Officer)DTDirk Thye(Executive Officer)inKen Bartizal(Executive Officer)inPDPaul Daruwala(Executive Officer)in

Co-investors5A5AM VenturesAIAisling CapitalBABain Capital Life SciencesFRFrazier Life SciencesRARA CapitalCACanaan Partners+1 more

Clasp Therapeutics develops off-the-shelf precision T cell engagers (its proprietary pHLАre molecules) that target mutant peptide-HLA complexes displayed on cancer cells, directing T cells to destroy tumors carrying common driver mutations such as KRas.

BiotechHealthtechCambridge, US

Co-investorsCACatalio Capital Management, LPCUCure VenturesCACatalio Capital ManagementNONovo HoldingsTHThird Rock Ventures

Lang Lai Technology (朗来科技) is a clinical-stage drug discovery company that runs an end-to-end new-drug R&D process spanning proof of concept, candidate compound screening, preclinical druggability development, and clinical research, pursuing both pipeline development and platform building.

BiotechHealthtechWuhan, CN

Co-investorsOROrbiMedLILilly Asia Ventures

Dutscher provides after-sales service (SAV) and post-delivery support (SAL) for laboratory equipment and consumables, handling warranty claims, non-warranty repairs, maintenance, product returns, and transport damage resolution.

Advanced ManufacturingB2B MarketplacesBiotechDeep TechE-commerceEnterprise SoftwareSaaS

Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.

BiotechMedical DevicesSan Mateo, US

ALAnn Lee-Karlon(Executive Officer, Director)inMitchell Mutz(Executive Officer, Director)James Wells(Director)

BoardSBSamuel Bjork(Director)inACAlexandra Cantley(Director)inSMSeiji Miyahara(Director)in

Co-investorsAVAvego BioScience CapitalGVGV (Google Ventures)MIMission BiocapitalNONovartis Venture FundRORoche Venture FundSASamsara BioCapital+4 more

Esco Aster provides independent technical and investor due diligence services across biotechnology, pharmaceuticals, medical technology, and related life sciences sectors.

BiotechDeep TechFoodTechHealthtechImpact & Social GoodMedical DevicesSingapore, SG

XLXL Linin

Evaheart develops implantable and extracorporeal ventricular assist devices for heart failure and vascular disease treatment.

BiotechHardwareHealthtechMedical DevicesChongqing, CN